No Data
No Data
Renovaro | 10-Q: Q1 2025 Earnings Report
Renovaro Biosciences Appoints Simon Tarsh as Interim CFO
Renovaro BioSciences Issues Shareholder Letter
Express News | Renovaro Issues Shareholder Letter and Provides Corporate Update
Express News | Renovaro Inc Files for Mixed Shelf Offering of up to $200 Mln- SEC Filing
Renovaro | 10-K/A: Annual report (Amendment)
No Data
No Data